comparemela.com

Latest Breaking News On - Rare disease group - Page 1 : comparemela.com

In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO s Mode of Action

Calliditas Therapeutics: In-Person & Virtual R&D Day: The Anti-Fibrotic Effects of Setanaxib and TARPEYO s Mode of Action

In Person & Virtual R&D Day: The Anti Fibrotic Effects of Setanaxib and TARPEYO s Mode of Action

Seer, Inc (NASDAQ:SEER) Q4 2022 Earnings Call Transcript

Agenda for Calliditas virtual R&D Day on January 20, 2021

Agenda for Calliditas virtual R&D Day on January 20, 2021 News provided by Share this article Calliditas Therapeutics AB (publ) ( Calliditas ) (Nasdaq OMX - CALTX) (NASDAQ - CALT) today announced the program for the upcoming virtual R&D Day for investors, analysts and journalists on January 20, 2021, which will take place between 1pm and 5pm CET. The R&D Day will feature presentations from executive management and Key Opinion Leaders and will be webcast live and accessible at: 1:00pm Professor Jonathan Barratt  CMO Dr Richard Phillipson Professor Jonathan Barratt 2:20pm 2:40pm  Head of North America Commercial, Andrew Udell, & Vice President Market Access, Christopher Ngai

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.